Lv6
2660 积分 2022-12-19 加入
Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines
27天前
已完结
Up-Front Treatment of Elderly (Age ≥75 Years) and Frail Patients With Multiple Myeloma
4个月前
已关闭
Optimizing drug therapies in cardiac amyloidosis
4个月前
已完结
Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy
4个月前
已完结
Administration of teclistamab in four patients with multiple myeloma requiring hemodialysis
4个月前
已完结
Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial
4个月前
已完结
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial
4个月前
已完结
A Phase II, Open-Label Study of an Accelerated Infusion Rate of Daratumumab in Patients with Relapsed and Refractory Multiple Myeloma
4个月前
已完结
Teclistamab for relapsed refractory multiple myeloma patients on dialysis
4个月前
已完结
Predicting the Future for AL Amyloidosis Patients With Cardiac Involvement
4个月前
已完结
皖公网安备34019202002308
